Gambogenic Acid Inhibits Basal Autophagy of Drug-Resistant Hepatoma Cells and Improves Its Sensitivity to Adriamycin.

Wang, Meng; Zhan, Fan; Cheng, Hui; Li, Qinglin

Wang, Meng; Zhan, Fan; Cheng, Hui; Li, Qinglin.

Affiliation

Wang M; Key Laboratory of Xin'an Medicine, Ministry of Education, Anhui Province Key Laboratory of R&D of Traditional Chinese Medicine, Anhui University of Chinese Medicine.
Zhan F; Huaibei Maternity & Child Healthcare Hospital.
Cheng H; Key Laboratory of Xin'an Medicine, Ministry of Education, Anhui Province Key Laboratory of R&D of Traditional Chinese Medicine, Anhui University of Chinese Medicine.
Li Q; Key Laboratory of Xin'an Medicine, Ministry of Education, Anhui Province Key Laboratory of R&D of Traditional Chinese Medicine, Anhui University of Chinese Medicine.

Biol Pharm Bull ; 45(1): 63-70, 2022.

Article in En | MEDLINE | ID: mdl-34980780

Subject(s)

Carcinoma, Hepatocellular; Doxorubicin; Apoptosis; Autophagy; Carcinoma, Hepatocellular/drug therapy; Carcinoma, Hepatocellular/metabolism; Cell Line, Tumor; Doxorubicin/pharmacology; Humans; Xanthenes

Key words

Adriamycin (ADM); apoptosis; autophagy; drug-resistant; gambogenic acid

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Doxorubicin / Carcinoma, Hepatocellular Type of study: Diagnostic_studies Limits: Humans Language: En Journal: Biol Pharm Bull Journal subject: BIOQUIMICA / FARMACOLOGIA Year: 2022 Type: Article

Fulltext

XML

PubMed Links

Search on Google